Pharmalittle: We’re reading about a J&J cough syrup, a Pfizer and Moderna patent suit, and more. By Ed Silverman April 15, 2024. ... Pfizer bought the company for $43 billion last year.

Pharma giant Pfizer has shelled out nearly US$120 million to acquire a small Australian company claiming to have developed a smartphone app that can accurately diagnose COVID-19 by analyzing the ...

An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular cough syrup Corex, two lawyers ...

As Pfizer plans to lean in on producing its COVID-19 antiviral this year—boosting the number of available Paxlovid treatments by 50% to more than 3.6 billion doses by the end of 2022—the drugmaker ...

Cough medicines have been under FDA scrutiny for the last few years, especially their use in children. The agency has said they should not be used in children 2 and younger, while manufacturers ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and refreshing, because that oh-so familiar routine of phone calls, online meetings, and ...

Pfizer recently paid over US$120 million to acquire a small Australian firm that claims to have created a smartphone app that can accurately detect COVID-19 by listening to cough, as reported ...